Siemens, The Ohio State Wexner Medical Center launch partnership
Both are looking to drive innovation in diagnostic and therapeutic imaging as well as AI and machine learning in radiology and radiation oncology.
Related Articles
New report urges guidelines — and some restrictions — on stem cell-based embryo models
New report urges guidelines — and some restrictions — on stem cell-based embryo models.
First Robotic Sleeve Gastrectomy Using Magnets in the US Performed at Cleveland Clinic
A recently approved device that incorporates magnetic technology reduces the number of incisions and gives the surgeon more control.
Molecular biology: The fundamental science fueling innovation
Molecular biology aims to understand the details of life by focusing closely on biopolymers—DNAs, RNAs, and proteins—and how they interact with one another. Advances in…
Improving Easy Access to Evidence-Based Medical Information, Part 2 – Physician’s Weekly
In the second part of their interview, PW editorial board member and regular contributor Alex McDonald, MD, FAAFP, and family medicine physician Frank Domino, MD…
AstraZeneca asthma drug more effective during attack than steroids, study finds
AstraZeneca’s Fasenra, an injectable treatment for severe asthma, is more effective during attacks than the oral steroid that has been the standard of care for…
Rheumatologists Recognize the Need to Create Pediatric Enthesitis Scoring Tool
At ACR, HCPLive spoke with Erin Treemarcki on a survey that showed many rheumatologists do not use established enthesitis scoring measures for children.
Twice-Yearly Lenacapavir for HIV Prevention in Men and Gender-Diverse Persons | NEJM
Twice-yearly subcutaneous lenacapavir has been shown to be efficacious for prevention of HIV infection in cisgender women. The efficacy of lenacapavir for preexposure prophylaxis (PrEP)…
Secret to eternal youth is within grasp: leading AI scientist
A leading AI scientist has said the technology and medical advancements needed to slow the aging process are just five years away.
Twice-Yearly Lenacapavir for HIV Prevention in Men and Gender-Diverse Persons | NEJM
Twice-yearly subcutaneous lenacapavir has been shown to be efficacious for prevention of HIV infection in cisgender women. The efficacy of lenacapavir for preexposure prophylaxis (PrEP)…
